BioCryst Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US09058V1035

SecurityBCRX / BioCryst Pharmaceuticals, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Barclays Plc ownership in BCRX / BioCryst Pharmaceuticals, Inc.

On May 15, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 0 shares of BioCryst Pharmaceuticals, Inc. (US:BCRX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 726,367 shares of BioCryst Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (BCRX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BCRX / BioCryst Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 0 -726,367 -100.00 0 -100.00
2026-02-13 2025-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 726,367 -55,865 -7.14 5,666 -4.58 0.0014
2026-03-31 2025-09-30 13F/A-3 BIOCRYST PHARMACEUTICALS COM 09058V103 782,232 -21,880 -2.72 5,937 -17.59 0.0013
2026-03-19 2025-09-30 13F/A-2 BIOCRYST PHARMACEUTICALS COM 09058V103 476,672 -327,440 3,623 0.0010
2025-11-12 2025-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 782,232 -21,880 5,937 0.0013
2026-02-27 2025-06-30 13F/A-2 BIOCRYST PHARMACEUTICALS COM 09058V103 804,112 401,512 99.73 7,205 138.62 0.0017
2025-08-14 2025-06-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 804,112 401,512 7 0.0017
2025-08-13 2025-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 804,112 401,512 7 0.0005
2026-03-17 2025-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 402,600 -61,646 -13.28 3,020 -13.52 0.0009
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 402,600 -61,646 3 0.0009
2026-03-19 2024-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 464,246 -12,426 -2.61 3,491 -3.62 0.0010
2025-02-13 2024-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 464,246 -12,426 3 0.0010
2026-03-31 2024-09-30 13F/A-2 BIOCRYST PHARMACEUTICALS COM 09058V103 476,672 250,086 110.37 3,623 158.71 0.0010
2024-11-19 2024-09-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 476,672 250,086 4 0.0010
2024-11-15 2024-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 476,672 250,086 4 0.0003
2026-03-23 2024-06-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 226,586 -49,672 -17.98 1,400 -0.21 0.0004
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 226,586 -49,672 1 0.0004
2026-03-24 2024-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 276,258 -428,271 -60.79 1,403 -66.75 0.0005
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 276,258 -428,271 1 0.0005
2026-03-25 2023-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 704,529 157,201 28.72 4,220 8.90 0.0015
2024-02-15 2023-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 704,529 157,201 4 0.0015
2026-03-26 2023-09-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 547,328 -2,411 -0.44 3,875 0.13 0.0024
2023-11-07 2023-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 547,328 -2,411 4 0.0024
2026-03-30 2023-06-30 13F/A-2 BIOCRYST PHARMACEUTICALS COM 09058V103 549,739 -153,434 -21.82 3,870 -34.00 0.0025
2023-09-20 2023-06-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 549,739 -153,434 4 0.0025
2023-08-03 2023-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 549,739 -153,434 4 0.0024
2026-03-30 2023-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 703,173 218,681 45.14 5,864 5.45 0.0027
2023-05-04 2023-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 703,173 218,681 6 0.0027
2026-03-30 2022-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 484,492 72,976 17.73 5,562 7.27 0.0025
2023-02-13 2022-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 484,492 72,976 6 0.0025
2022-11-03 2022-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 411,516 324,633 373.64 5,184 464.71 0.0057
2022-08-12 2022-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 86,883 -35,444 -28.97 918 -53.85 0.0006
2022-05-16 2022-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 122,327 -96,205 -44.02 1,989 -34.29 0.0016
2022-02-23 2021-12-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 218,532 139,616 176.92 3,027 166.93 0.0011
2022-02-14 2021-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 218,532 139,616 3,027 0.0003
2021-11-09 2021-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 78,916 -3,253 -3.96 1,134 -12.70 0.0005
2021-08-13 2021-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 82,169 -153,124 -65.08 1,299 -45.72 0.0006
2021-05-13 2021-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 235,293 137,263 140.02 2,393 227.81 0.0013
2021-02-11 2020-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 98,030 -189,675 -65.93 730 -26.04 0.0004
2020-11-12 2020-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 287,705 -86,006 -23.01 987 -44.52 0.0006
2020-08-12 2020-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 373,711 -775,135 -67.47 1,779 -22.58 0.0014
2020-05-13 2020-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,148,846 949,442 476.14 2,298 234.01 0.0018
2020-02-10 2019-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 199,404 -33,802 -14.49 688 2.84 0.0004
2019-11-15 2019-09-30 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 233,206 -127,631 -35.37 669 -51.10 0.0004
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 233,206 -127,631 669 154.6736
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 360,837 255,012 240.98 1,368 58.89 0.0008
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 105,825 64,891 158.53 861 160.91 0.0006
2019-02-14 2018-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 40,934 -4,214 -9.33 330 -4.35 0.0003
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 45,148 34,050 306.81 345 439.06 0.0002
2018-08-14 2018-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 11,098 -18,376 -62.35 64 -54.29 0.0001
2018-05-15 2018-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 29,474 5,801 24.50 140 20.69 0.0001
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 23,673 8,778 58.93 116 48.72 0.0001
2017-11-14 2017-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 14,895 -147,821 -90.85 78 -91.37 0.0001
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 162,716 138,029 559.12 904 334.62 0.0010
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 24,687 -37,777 -60.48 208 -47.47 0.0002
2017-02-14 2016-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 62,464 61,050 4,317.54 396 5,557.14 0.0004
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 1,414 -17,159 -92.39 7 -86.54 0.0000
2016-08-12 2016-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 18,573 -2,095 -10.14 52 26.83 0.0001
2016-05-16 2016-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 20,668 3,231 18.53 41 -76.57 0.0001
2016-02-12 2015-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 17,437 -63,280 -78.40 175 -80.27 0.0002
2015-11-13 2015-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 80,717 31,633 64.45 887 29.30 0.0011
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 49,084 45,902 1,442.55 686 2,265.52 0.0008
2015-05-19 2015-03-31 13F/A-1 BIOCRYST PHARMACEUTICALS COM 09058V103 3,182 -3,109 -49.42 29 -61.33 0.0000
2015-05-14 2015-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 3,182 29
2015-02-13 2014-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 6,291 -4,817 -43.37 75 -25.00 0.0001
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 11,108 -4,147 -27.18 100 -45.05 0.0001
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 15,255 4,915 47.53 182 76.70 0.0002
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 10,340 -13,668 -56.93 103 -38.69 0.0001
2014-02-13 2013-12-31 13F BIOCRYST PHARMACEUTICALS COM 09058V103 24,008 -2,082 -7.98 168 -8.20 0.0002
2013-11-14 2013-09-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 26,090 -143,196 -84.59 183 -30.15 0.0002
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS COM 09058V103 169,286 169,286 262 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-11-19 2024-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Call 0 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 0 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A BIOCRYST PHARMACEUTICALS OPT Call 10,000 62 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 10,000 0 n/a n/a n/a
2021-11-09 2021-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-13 2021-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 34,400 -33.07 544 4.02 n/a n/a n/a
2021-05-13 2021-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 51,400 49.42 523 -3.86 n/a n/a n/a
2021-02-11 2020-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-12 2020-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 68,400 -55.03 235 -67.59 n/a n/a n/a
2020-08-12 2020-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 152,100 122.37 725 208.51 n/a n/a n/a
2020-05-13 2020-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-10 2019-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 13,600 353.33 47 422.22 n/a n/a n/a
2019-11-15 2019-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Call 3,000 -33.33 9 -47.06 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 3,000 9 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 4,500 246.15 17 54.55 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 1,300 -96.33 11 -96.15 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 35,400 15.69 286 22.75 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 30,600 38.46 233 83.46 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 22,100 118.81 127 164.58 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 10,100 -74.94 48 -75.76 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 40,300 27.13 198 19.28 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 31,700 -75.60 166 -77.01 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 129,900 448.10 722 262.81 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 23,700 169.32 199 255.36 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 8,800 -92.31 56 -88.91 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 114,400 4,476.00 505 7,114.29 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 2,500 -59.02 7 -41.67 n/a n/a n/a
2016-05-16 2016-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 6,100 -79.67 12 -96.00 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 30,000 4.17 300 -5.36 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 28,800 8.27 317 -14.78 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 26,600 1.92 372 58.30 n/a n/a n/a
2015-05-19 2015-03-31 13F/A BIOCRYST PHARMACEUTICALS OPT Call 26,100 -74.03 235 -80.51 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 26,100 235 n/a n/a n/a
2015-02-13 2014-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 100,500 3.82 1,206 38.46 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 96,800 57.14 871 17.86 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 61,600 72.07 739 106.42 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS OPT Call 35,800 24.31 358 77.23 n/a n/a n/a
2014-02-13 2013-12-31 13F BIOCRYST PHARMACEUTICALS OPT Call 28,800 -32.39 202 -32.21 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOCRYST PHARMACEUTICALS OPT Call 42,600 735.29 298 3,625.00 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS OPT Call 5,100 8 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-03-19 2025-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Put 10,000 76 n/a n/a n/a
2026-03-17 2025-03-31 13F/A BIOCRYST PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-03-19 2024-12-31 13F/A BIOCRYST PHARMACEUTICALS OPT Put 10,000 0.00 75 -1.32 n/a n/a n/a
2025-02-13 2024-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 10,000 0 n/a n/a n/a
2024-11-19 2024-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Put 10,000 0 n/a n/a n/a
2026-03-31 2024-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Put 10,000 76 n/a n/a n/a
2024-11-15 2024-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 10,000 0 n/a n/a n/a
2026-03-23 2024-06-30 13F/A BIOCRYST PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A BIOCRYST PHARMACEUTICALS OPT Put 20,000 -66.67 102 -71.87 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 20,000 0 n/a n/a n/a
2026-03-25 2023-12-31 13F/A BIOCRYST PHARMACEUTICALS OPT Put 60,000 359 n/a n/a n/a
2024-02-15 2023-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 60,000 0 n/a n/a n/a
2019-11-15 2019-09-30 13F/A BIOCRYST PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 211,500 91.92 802 -10.59 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 110,200 670.63 897 680.00 n/a n/a n/a
2019-02-14 2018-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 14,300 -30.92 115 -27.22 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 20,700 218.46 158 327.03 n/a n/a n/a
2018-08-14 2018-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 6,500 -10.96 37 5.71 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 7,300 -66.67 35 -67.59 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 21,900 -11.34 108 -16.28 n/a n/a n/a
2017-11-14 2017-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 24,700 30.00 129 21.70 n/a n/a n/a
2017-08-14 2017-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 19,000 120.93 106 47.22 n/a n/a n/a
2017-05-15 2017-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 8,600 352.63 72 500.00 n/a n/a n/a
2017-02-14 2016-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 1,900 -88.48 12 -83.56 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 16,500 1,169.23 73 1,725.00 n/a n/a n/a
2016-08-12 2016-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 1,300 -58.06 4 -33.33 n/a n/a n/a
2016-05-16 2016-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 3,100 -82.08 6 -96.53 n/a n/a n/a
2016-02-12 2015-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 17,300 143.66 173 121.79 n/a n/a n/a
2015-11-13 2015-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 7,100 -14.46 78 -32.76 n/a n/a n/a
2015-08-14 2015-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 8,300 -45.39 116 -15.33 n/a n/a n/a
2015-05-19 2015-03-31 13F/A BIOCRYST PHARMACEUTICALS OPT Put 15,200 -22.05 137 -41.45 n/a n/a n/a
2015-05-14 2015-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 15,200 137 n/a n/a n/a
2015-02-13 2014-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 19,500 -0.51 234 32.95 n/a n/a n/a
2014-11-14 2014-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 19,600 -13.66 176 -35.29 n/a n/a n/a
2014-08-14 2014-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 22,700 5.09 272 25.93 n/a n/a n/a
2014-05-15 2014-03-31 13F BIOCRYST PHARMACEUTICALS OPT Put 21,600 453.85 216 700.00 n/a n/a n/a
2014-02-13 2013-12-31 13F BIOCRYST PHARMACEUTICALS OPT Put 3,900 -95.70 27 -95.74 n/a n/a n/a
2013-11-14 2013-09-30 13F BIOCRYST PHARMACEUTICALS OPT Put 90,600 3,384.62 634 15,750.00 n/a n/a n/a
2013-08-14 2013-06-30 13F BIOCRYST PHARMACEUTICALS OPT Put 2,600 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.